Kenya is going ahead with its plan to inoculate its citizens against Covid-19 using a vaccine developed by AstraZeneca, a senior health ministry official has said, dismissing concerns over its efficacy.
Kenya expects to receive 24 million doses of the vaccine beginning this month, said Mercy Mwangangi, the chief administrative secretary at the ministry.
“We are going to continue with AstraZeneca because we are doing our own sequencing and we are comfortable to move forward with it,” she told Reuters.
